Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo

The 5-year survival rate for pancreatic ductal adenocarcinoma (PDAC) remains dismal despite current chemotherapeutic agents and inhibitors of molecular targets. As the incidence of PDAC constantly increases, more effective multidrug approaches must be made. Here, we report a novel method of deliveri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sorah, Huang, Kai-Wen, Reebye, Vikash, Mintz, Paul, Tien, Yu-Wen, Lai, Hong-Shiee, Sætrom, Pål, Reccia, Isabella, Swiderski, Piotr, Armstrong, Brian, Jozwiak, Agnieszka, Spalding, Duncan, Jiao, Long, Habib, Nagy, Rossi, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923325/
https://www.ncbi.nlm.nih.gov/pubmed/26983359
http://dx.doi.org/10.1038/mt.2016.60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923325/
https://www.ncbi.nlm.nih.gov/pubmed/26983359
http://dx.doi.org/10.1038/mt.2016.60

Ejemplares similares